Objective: The objective of the study was to evaluate the prevalence of metabolic syndrome and its components in 2010.
T he metabolic syndrome is characterized by a constellation of medical disorders, including abdominal obesity, high blood pressure, high blood glucose, increased triglycerides, and decreased high-density lipoprotein cholesterol (HDL-C) (1) . The metabolic syndrome has dramatically increased worldwide (2) (3) (4) (5) (6) (7) (8) , even as cardiovascular disease is becoming increasingly common in economically developing countries (9) . Given the enormous health and economic burden imposed by diseases associated with the metabolic syndrome, particular attention needs to be paid to the current prevalence of metabolic syndrome and its components.
According to data from the International Collaborative Study of Cardiovascular Disease in ASIA (InterASIA), the age-standardized prevalence of the metabolic syndrome defined by the US National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria in Chinese adults aged 35 to 74 years was 9.8% in men and 17.8% in women in 2000 to 2001 (10) . By 2008, the prevalence of metabolic syndrome defined using the criteria established by the Chinese Joint Committee for Developing Chinese Guidelines (JCDCG) rose to 25.8% in men and 18.0% in women, according to a survey performed in 46,239 Chinese residents 20 years of age or older from 14 provinces (11) . Due to socioeconomic growth, Chinese population is undergoing lifestyle transition, which may contribute to the progression of metabolic disorders. To provide a comprehensive and accurate estimation of the current prevalence of metabolic syndrome and its components, the Key Laboratory for Endocrine and Metabolic Diseases of the Chinese Ministry of Health and the Chinese Center for Disease Control and Prevention (China CDC) collaboratively conducted the 2010 China Noncommunicable Disease Surveillance. The objective of this study was to estimate the prevalence of metabolic syndrome and examine whether metabolic syndrome is associated with the 10-year coronary heart disease (CHD) risk in Chinese adults.
Methods

Study design and population
The 2010 China Noncommunicable Disease Surveillance was conducted at 162 study sites from the China CDC's National Disease Surveillance Point System, which was designed to select a nationally representative sample of the general population, covering all 31 provinces, autonomous regions, and municipalities of mainland China (12) . The study population, design, and protocols have been described previously (13) . To select the 162 study sites, a multistage cluster probability sampling was designed with stratification at 3 levels. The first level of stratification was according to 7 geographic regions (Northeast, North, East, South, Southwest, Northwest, and Central areas) and 3 municipalities (Beijing, Tianjin, and Shanghai) in China. The second level was based on the urban or rural locations of the study sites. Within rural areas, a third level of stratification was based on a classification of rural sites into 4 socioeconomic strata. Also, urban areas were reclassified according to population size into big cities, middle-sized cities, and small cities. The Surveillance Point System includes approximately 1% of the total Chinese population (12) .
At each site, a complex, multistage, probability sampling design was used to select participants who were representative of civilian, noninstitutionalized Chinese adults. Only persons who had been living at their current residence for 6 months or longer were eligible to participate. In the first stage, 4 subdistricts in urban areas or townships in rural areas were selected from each site with probability proportional to the size of their population. In the second stage, 3 neighborhood communities or administrative villages were selected with probability proportional to the size of their population. In the third stage, households within each neighborhood community or administrative village were listed. A sample of at least 50 households was randomly drawn. In the final stage, individuals were chosen to participate in the survey from a list of all persons residing in selected households. A Kish selection table was used to randomly select only 1 person aged 18 years or older from each household. Replacement with someone from a similar household in the same or a nearby neighborhood or village was implemented randomly if the selected individual did not participate. The replacements were used to ensure an adequate sample size within each selected neighborhood community or administrative village and to maximize the national representativeness of the surveyed samples with regard to geographic distribution, economic development, and urbanization. The households in our study were categorized into single person households, families of couples who were married or cohabiting adults with or without children, single-parent families, or households with 3 or more cohabiting generations. The household composition information was obtained from the government household registration system, which includes personal identifiers such as name, parents, spouse, and date of birth for each member within a household who is a local permanent resident. If the second household did not participate, a third household was selected. All replacements were successfully recruited by the third sampling. If no available replacement was found in the same neighborhood or village, the nearest neighborhood or village was used. A total of 109,023 people were selected and 98,658 participated in the survey. The overall response rate was 90.5%. The overall replacement rate was 9.25%. For this report, we excluded persons without complete information on metabolic syndrome status and 97,098 participants were included in the present analyses.
The study protocol was approved by the Ethical Review Committee of China CDC and other participating institutes. Written informed consent was obtained from each participant.
Data collection
At each study site, trained staff collected data according to a standard protocol in examination centers at local health stations or community clinics in the participants' residential area.
Questionnaire information including demographic characteristics, history of cardiovascular disease, cigarette smoking, alcohol consumption, and physical activities was recorded. The Global Physical Activity Questionnaire was used to estimate physical activity during work, transportation, and leisure time by collecting intensity, duration, and frequency of physical activity. Low physical activity was defined according to the Global Physical Activity Questionnaire Analysis Guide. Waist circumference was measured in standing subjects midway between the lower edge of the costal arch and the upper edge of the iliac crest. Body mass index (BMI) was calculated as body weight in kilograms divided by body height squared in meters (kg/m 2 ). Blood pressure was measured in the nondominant arm of seated participants 3 times consecutively at 1-minute interval after at least 5 minutes of rest using an automated electronic device (OMRON Model HEM-7071, Omron Company). The 3 readings were averaged for analysis.
Blood samples were collected for all participants after an overnight fasting for at least 10 hours. Blood specimens were processed at the field center. Glucose samples were collected using vacuum blood collection tubes containing anticoagulant sodium fluoride and were centrifuged at 4°C on site within 2 hours of collection. Plasma glucose concentrations were measured at the local hospital within 24 hours under a stringent quality control mechanism. Serum samples were aliquoted into 0.5-ml Eppendorf tubes within 2 hours and shipped by air in dry ice at -80°C to the central laboratory, which was certified by the College of American Pathologists, in Shanghai Institute of Endocrine and Metabolic Diseases, where serum lipid profile including levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), HDL-C, and triglycerides was measured using an autoanalyser (Abbott Laboratories, Chicago, IL). All study laboratories successfully completed a standardization and certification program.
Quality control
A well-defined, comprehensive quality control was implemented to ensure data validity. A pilot investigation of 200 subjects was conducted 3 months before launching the national surveillance. The investigating staff then underwent 1 week training of study protocol and standard operation procedure, and received performance assessment by onsite simulation. Only those who had passed could go on with data collection. Members of the steering committee supervised the entire process of field investigation on the first day of data collection at each site.
All of the laboratories in local hospitals conducted a 5-day performance validation test for glucose measurement before site investigation was carried out. Test results were evaluated by 2 senior laboratorians independently at the central laboratory, and only those who passed the test were qualified for plasma glucose evaluation. During the investigation, inter-and intralaboratory quality control were implemented on each of the testing days. If the laboratory failed the internal quality control, causes were then identified, appropriate modifications were applied, and all blood samples were re-evaluated. Measurement for lipid profile was conducted in our College of American Pathologists-certified central laboratory in Shanghai with strict compliance with laboratory quality control procedures.
Definition and diagnostic criteria
The metabolic syndrome was defined according to the revised NCEP ATP III criteria (2004) with modification on waist circumference cutoff to be more appropriate for an Asian population. The metabolic syndrome was diagnosed when 3 or more of the following criteria were met in a participant: (a) blood pressure $130/85 mm Hg or taking antihypertensive drugs, (b) waist circumference $90 cm in men and $80 cm in women, (c) triglycerides level $1.69 mmol/L (150 mg/dL), (d) HDL-C level ,1.03 mmol/L (40 mg/dL) in men and ,1.29 mmol/L (50 mg/dL) in women, and (e) fasting plasma glucose level $5.6 mmol/L (100 mg/dL) or taking hypoglycemic medications (14) .
The recalibrated Framingham functions in the Chinese Multiprovincial Cohort Study cohort were adopted to evaluate the 10-year CHD risk. The equations for estimating the 10-year CHD risk were developed from sex-specific proportional hazards models that included the covariates of age, systolic blood pressure level, TC, and HDL-C levels, current smoking status (yes or no), and history of diabetes (yes or no) (15) .
Statistical analysis
All statistical analyses were performed with SAS version 9.3 (SAS Institute Inc., Cary, NC) and SUDAAN version 10.0 (Research Triangle Institute, Research Triangle Park, NC). Each participant was assigned an analysis weight, which was computed on the basis of the Chinese population census data of 2010, taking into consideration the sampling scheme of the current study as well as major demographic differences between the sample and the total population, so that estimates were representative of civilian noninstitutionalized Chinese adults. The Taylor-linearization method was used for the calculation of standard errors to account for the complex sampling design.
Demographic and metabolic features were described by sex using percentages [95% confidence intervals (CIs)] for categorical variables and means (95% CI) for continuous variables. Estimates of the prevalence of metabolic syndrome and its components were calculated for the overall population and different subgroups by sex (men/women), region (rural/urban areas), economic development levels (underdeveloped/ intermediate developed/developed), ethnic groups (Han Chinese/minorities), education levels (,9/$9 years), physical activities (low/normal). Each 1 of the 162 study sites was categorized into underdeveloped, intermediately developed, or developed region according to tertiles of their gross domestic product (GDP) per capita in 2009. Additionally, we divided the participants into 2 groups: participants with high 10-year risk of CHD (predicted 10-year risk $7.5%) and those with low 10-year risk of CHD (predicted 10-year risk ,7.5%). To further explore whether metabolic syndrome is associated with the 10-year risk of CHD, sex-stratified logistic regression models were used.
The P values reported are 2-sided, and P , 0.05 indicates statistical significance.
Results
General characteristics
Among the participants in this analysis, 45.7% (n = 44,413) were men and 54.3% (n = 52,685) were women. Men were more likely than women to smoke cigarette, consume alcohol, and had a higher level of education and a lower level of physical activity. Nearly all of the metabolic risk factors including BMI, waist circumference, blood pressures, TC, LDL-C, triglycerides, and fasting plasma glucose concentrations were significantly higher in men than in women, whereas the HDL-C level was lower (all P , 0.0001; Table 1 ).
Prevalence of metabolic syndrome
The estimate of overall prevalence of metabolic syndrome in the year 2010 by this national surveillance of residents in mainland China was 33.9% (95% CI, 33.5 to 34.2), which indicates that metabolic syndrome affects approximately 454 million adults in China. The prevalence in women was significantly higher than that in men, 36.8% (95% CI, 36.3 to 37.3) vs 31.0 (95% CI, 30.4 to 31.5), P , 0.0001 [ Fig. 1(A) ]. The estimated prevalence of metabolic syndrome in urban residents was 37.8% (95% CI, 37.2 to 38.4), which was higher than that in rural counterparts, 32.1% (95% CI, 31.6 to 32.6), P , 0.0001 [ Fig. 1(B) ]. The estimated prevalence of metabolic syndrome gradually rose with the level of economic development (P for trend , 0.0001), and this pattern held for both male and female residents [ Fig. 1(C) ].
Prevalence of metabolic syndrome components
The prevalence of components of the metabolic syndrome in the total study population and in subgroups is shown in Table 2 . More than half of the total adult participants were suffering from low HDL-C. Abdominal obesity and low HDL-C were more prevalent in women than in men, whereas high blood pressure, high blood glucose, and high triglycerides were more common in men than in women. The prevalence of individual components of the metabolic syndrome was remarkably higher in urban compared with rural areas, except for high blood pressure. Notably, the prevalence of individual components elevated with the increasing economic development level (all P for trend , 0.0001).
The prevalence of metabolic syndrome and individual components were remarkably higher in Han ethnicity compared with others, except for low HDL-C, which was 60.2% (95% CI, 59.8 to 60.7) in Han Chinese and 64.5% (95% CI, 63.4 to 65.6) in minorities (P , 0.0001). Participants with lower education level (education duration ,9 years) had a higher prevalence of abdominal obesity, high blood glucose, high blood pressure, and metabolic syndrome, but a lower prevalence of high triglycerides and low HDL-C compared with participants with higher education level. The prevalence of metabolic syndrome and its components elevated in participants with low physical activity level (all P , 0.0001; Table 2 ).
Association between metabolic syndrome and the estimated 10-year risk of CHD Table 3 shows the multivariate odds ratios and the corresponding 95% CIs for the association of metabolic syndrome and other potential risk factors with a high 10-year risk of CHD. Independent risk factors included increasing age, increasing LDL-C, and metabolic syndrome in men, and increasing age, increasing BMI, and metabolic syndrome in women. Metabolic syndrome was associated with a higher 10-year risk of CHD even after adjustment for each component of metabolic syndrome as continuous variables.
Discussion
Our study, based on the 2010 China Noncommunicable Disease Surveillance, provided the latest estimate of the national prevalence of metabolic syndrome among adults aged 18 years and older in mainland China. Thus, this study revealed that for the year of 2010, the estimated prevalence of metabolic syndrome was 33.9%, which indicates that metabolic syndrome affects approximately 454 million adults in China. Over the past decades, the prevalence of metabolic syndrome has grown markedly worldwide (2) (3) (4) (5) (6) (7) (8) . The epidemic of metabolic syndrome is mainly explained by urbanization, industrialization, an aging population, and lifestyle transition. Recently, data from the US National Health and Nutrition Examination Survey reported a metabolic syndrome prevalence of nearly 35% in 2011 to 2012 and suggested that the prevalence has remained stable overall since 2007 and declined in women (5) . It is noteworthy that our study used lower cutoff points for abdominal obesity according to the International Obesity Task Force criteria for the Asian-Pacific population. However, the epidemiological characteristics of metabolic syndrome vary according to region, lifestyle pattern, socioeconomic status, and changes. The prevalence of metabolic syndrome has increased rapidly in Asia, especially in countries undergoing economic transition (6) (7) (8) . Soo Lim et al. (7). A cross-sectional study conducted in adults aged 20 to 80 years of the urban of Eastern India reported a metabolic syndrome prevalence of 33.5% overall, 24.9% in men and 42.3% in women (8) . These studies demonstrated that metabolic syndrome has become serious public health challenge in China and other Asian populations, and therefore should be given sufficient attention.
In China, data from the InterASIA study, a crosssectional survey conducted in 15,540 Chinese adults aged 35 to 74 years in 2000 to 2001 (10), revealed an agestandardized metabolic syndrome prevalence of 9.8% in men and 17.8% in women. Given the different definition of metabolic syndrome, we further divided our population into the same age groups as those in the InterASIA study and used the same US NCEP ATP III criteria with the InterASIA study as the definition of the metabolic press.endocrine.org/journal/jcemsyndrome to evaluate the change of the prevalence (Supplemental Fig. 1 ). Compared with that in the InterASIA study, the prevalence of the metabolic syndrome was higher in every age group, for both men and women, indicating that metabolic syndrome prevalence has increased overall and at each age level as well. The National Diabetes and Metabolic Disorders Survey conducted in 2007 to 2008, involving 46,239 Chinese residents aged 20 or older, showed that prevalence of metabolic syndrome was 25.8% in men and 18.0% in women, according to the criteria established by the JCDCG (11) . To facilitate comparison, we calculated the prevalence of metabolic syndrome according to the JCDCG definition and demonstrated that the estimated prevalence of metabolic syndrome was 27.3% in men and 27.5% in women, which was significantly higher than that was estimated in the National Diabetes and Metabolic Disorders Survey. However, the direct comparison of prevalence rates between our study and other studies needs caution because of potential differences in sampling of study populations, methods of data collection, and statistical analysis. Nevertheless, our results indicated a Age, parental history of diabetes and hypertension, level of education, daily alcohol consumption, physical activity levels, BMI, and LDL-C were adjusted in the model. b Age, parental history of diabetes and hypertension, level of education, daily alcohol consumption, physical activity levels, BMI, LDL-C, and components of metabolic syndrome as continuous variables (waist circumference, systolic blood pressure, diastolic blood pressure, HDL-C, triglycerides and fasting plasma glucose) were adjusted in the model. that the prevalence of the metabolic syndrome was dramatically increased during the past 10 years, since 2000 and 2001 to 2010; in the meantime, the overall severity of the metabolic syndrome was heavier in China population in 2010 than in 2000. In that time, China has undergone a series of remarkable transformations, leading to rapid economic growth, industrialization, and urbanization. In consideration of the consequential chronic diseases, such as cardiovascular diseases and diabetes, which the metabolic syndrome might lead to, the high growth rate of the metabolic syndrome in China should bring to the attention of the public health that the prevention and treatment of the metabolic syndrome is a crucial task which brooks of no delay. We found higher prevalence of the metabolic syndrome and its components in urban area than in rural area, in accordance with previous studies in China that have documented regional variations in the prevalence of chronic diseases, such as hypertension, obesity, and diabetes (16) (17) (18) (19) (20) . Urbanization is characterized by changes in lifestyle that lead to sedentary behavior, high caloric diet, and environmental contaminant exposure, all of which are known to be critical contributors to the development of the metabolic syndrome (18, 21, 22) . In our analysis, stratified by different levels of GDP per capita, the prevalence of the metabolic syndrome and its components gradually and significantly increased along with rising level of GDP per capita, and this trend was consistent in both sexes. Our results lend support to the postulation that the level of economic growth may explain the geographic variation in the prevalence of the metabolic syndrome. Notably, variation in its prevalence was in parallel with variation in GDP levels. The societal implications of the associations between high prevalence of metabolic syndrome and high GDP observed in our study are profound, and all developing countries should learn this lesson from China.
The metabolic syndrome is a key driver of the increased risk of cardiovascular disease and diabetes morbidity and mortality (23) (24) (25) (26) (27) (28) (29) , leading to a major health problem and an enormous burden to society (30, 31) . Consistent with prior studies, we found that the metabolic syndrome was associated with an increased 10-year risk of CHD. These findings demonstrate that the metabolic syndrome is an important risk factor for cardiovascular diseases and suggest the need to manage metabolic syndrome and related cardiovascular diseases effectively to avoid preventable morbidity and premature mortality.
This study has several strengths. First, this investigation was based on the data from the China Noncommunicable Disease Surveillance, which enrolled participants from all 31 provinces, autonomous regions, or municipalities of mainland China with a complex, multistage, probability sampling design and enabled us to derive unbiased prevalence estimates. Second, great efforts were made to implement strict and rigid quality control at every step of the study to ensure data validity and reliability. Third, we have assessed associations between economic development and risks of metabolic syndrome in China in great detail.
Several potential limitations of our study need to be acknowledged. First, 9.5% of selected subjects did not participate in the survey, which could potentially undermine the representativeness of the study samples. However, the replacements were used to maximize the national representativeness of the study samples regarding geographic distribution, economic development, and urbanization. Second, the effect of population mobility must be considered, and the results should therefore be influenced by selecting bias. Third, because of the cross-sectional nature of this study, no causal inferences can be drawn. Finally, we did not collect validated information about cardiovascular diseases, but rather we used the predicted 10-year risk of CHD using a risk score appropriate for Chinese adults.
In summary, our data showed a high prevalence of the metabolic syndrome and its components in the general adult population in mainland China. Our findings indicated that the metabolic syndrome has become a huge public health burden in China, which was found to be associated with a high risk of CHD. Strategies must be found to control the high prevalence of the metabolic syndrome in China.
